noema pharma | Noema Pharma - BEYOND SYMPTOM CONTROL

Keyword	CPC	PCC	Volume	Score	Length of keyword
noema pharma	0.67	0.8	9060	2	12
noema	0.26	0.4	5145	39	5
pharma	1.62	0.7	8528	78	6

Keyword	CPC	PCC	Volume	Score
noema pharma	1.19	0.5	8095	35
noema pharma ag	0.48	0.3	3844	1
noema pharma careers	0.32	0.1	3886	23
noema pharma basel	1.02	0.4	8467	22
noema pharma address	0.57	0.4	4371	62
noema pharma conference 2024	1.37	0.1	538	9
noema pharma france	0.4	0.8	308	80
noema pharma series b	0.08	0.6	6840	21
noema pharmaceuticals	0.28	0.5	340	67
noema pharma australia	0.06	0.8	4727	93
noema pharma us	1.53	0.5	8684	72

Search Results related to noema pharma on Search Engine

Noema Pharma - BEYOND SYMPTOM CONTROL
noemapharma.com

https://noemapharma.com/

WEBBEYOND SYMPTOM CONTROL. Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their lives to the fullest. Who We Are. Noema Pharma is a clinical-stage biotech company targeting debilitating central nervous system (CNS) indications. Learn About Noema. Our Pipeline.

DA: 42 PA: 86 MOZ Rank: 77

Noema Pharma
noemapharma.com

https://noemapharma.com/pipeline/

WEBNoema Pharma. Our Pipeline. A Singular Focus on CNS Conditions. Noema Pharma is committed to developing treatments for debilitating disorders of the central nervous system (CNS), conditions characterized by imbalanced neuronal networks leading to unresolved severe symptoms and significant impact on patients’ lives.

DA: 30 PA: 64 MOZ Rank: 45

Who We Are | Noema Pharma
noemapharma.com

https://noemapharma.com/about-us/

WEBOur pipeline contains novel therapies designed to address debilitating central nervous system (CNS) disorders in order to improve quality of life and patient outcomes. We partner with patients, families and caregivers, and healthcare professionals to provide a comprehensive approach beyond treating symptoms to ensure that patients ...

DA: 4 PA: 80 MOZ Rank: 2

Noema Pharma
noemapharma.com

https://noemapharma.com/news-events/

WEBJun 21, 2021 · Noema Pharma to Present at Two Upcoming Conferences. January 3, 2024 Press Release. BASEL, Switzerland, January 3, 2024 — Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management ...

DA: 4 PA: 72 MOZ Rank: 72

Noema Pharma
noemapharma.com

https://noemapharma.com/careers/

WEBAt Noema Pharma, we are committed to improving the lives of people affected by debilitating central nervous system (CNS) disorders. As emerging leaders in the field, we’re looking for multidisciplinary talents who are passionate about the patients and science associated with these disorders.

DA: 54 PA: 81 MOZ Rank: 61

Noema Pharma raises CHF 103 million (USD 112 million) in …
noemapharma.com

https://noemapharma.com/2023/03/07/noema-pharma-raises-chf-103-million-usd-112-million-in-series-b-financing-round-led-by-forbion-and-jeito-capital/

WEBBASEL, Switzerland, March 7, 2023 – Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that it has successfully closed an oversubscribed Series B financing round, raising CHF 103 million (approx. USD 112 million) from new and existing investors.

DA: 8 PA: 45 MOZ Rank: 7

Noema Pharma receives FDA Fast Track designation
noemapharma.com

https://noemapharma.com/2022/10/18/noema-pharma-receives-fda-fast-track-designation/

WEBOct 18, 2022 · Noema Pharma (www.noemapharma.com) is a clinical-stage Biotech company targeting debilitating central nervous system (CNS) indications characterized by imbalanced neuronal networks. The company is actively developing three mid-clinical-stage therapeutic product candidates in-licensed from Roche.

DA: 79 PA: 81 MOZ Rank: 84

Press Release | Noema Pharma
noemapharma.com

https://noemapharma.com/category/press-release/

WEBBASEL, Switzerland, January 3, 2024 — Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in …

DA: 52 PA: 98 MOZ Rank: 58

Noema Pharma Announces FDA Investigational New Drug (IND)
globenewswire.com

https://www.globenewswire.com/news-release/2022/06/27/2469443/0/en/Noema-Pharma-Announces-FDA-Investigational-New-Drug-IND-Authorization-for-Orpheus-Phase-2b-Study-of-PDE10A-Inhibitor-Gemlapodect-NOE-105-in-Childhood-Onset-Fluency-Disorder.html

WEBJun 27, 2022 · Noema Pharma ( www.noemapharma.com) is a clinical-stage Biotech company targeting debilitating central nervous system (CNS) indications characterized by imbalanced neuronal networks. The...

DA: 28 PA: 82 MOZ Rank: 68

Noema Pharma Receives FDA Fast Track Designation for
globenewswire.com

https://www.globenewswire.com/news-release/2022/10/18/2536323/0/en/Noema-Pharma-Receives-FDA-Fast-Track-Designation-for-basimglurant-NOE-101-in-Trigeminal-Neuralgia.html

WEBOct 18, 2022 · Noema Pharma ( www.noemapharma.com) is a clinical-stage Biotech company targeting debilitating central nervous system (CNS) indications characterized by imbalanced neuronal networks. The...

DA: 92 PA: 12 MOZ Rank: 47